Stock listing
NASDAQ:LABT Lakewood-Amedex Biotherapeutics Inc. Stock
Home listing (NASDAQ) of Lakewood-Amedex Biotherapeutics Inc.
Follow Lakewood-Amedex Biotherapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LABT
$0.191 USD -0.004 (-1.8%)
Close on Nov 4, 2026
- Day range
- $0.173 – $0.200 USDNov 4, 2026
- Volume
- 790,865 sharesNov 4, 2026
- Market cap
- $453,558 USDAt the close on Nov 4, 2026 · price × 2.37M shares outstanding
- Traded on an average day
- $2.16M USDMedian day 167,850 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LABT · Home | $0.191 USD | -0.004 (-1.8%) | 790,865 | $0.189 | $0.200 | $0.173 | $0.195 | Close on Nov 4, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NASDAQ:LABT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.191 | -0.004 | -1.8% | $0.189 | $0.200 | $0.173 | 790,865 | |
| $0.195 | +0.010 | +5.4% | $0.179 | $0.205 | $0.171 | 827,353 | |
| $0.185 | -0.015 | -7.5% | $0.192 | $0.195 | $0.169 | 1,302,047 | |
| $0.200 | -0.040 | -16.7% | $0.197 | $0.220 | $0.195 | 1,499,649 | |
| $0.240 | -0.050 | -17.2% | $0.240 | $0.240 | $0.220 | 4,128,300 | |
| $0.290 | 0.000 | 0.0% | $0.280 | $0.290 | $0.250 | 24,887,400 | |
| $0.290 | +0.010 | +3.6% | $0.250 | $0.290 | $0.240 | 1,423,200 | |
| $0.280 | -0.030 | -9.7% | $0.270 | $0.280 | $0.240 | 2,789,800 | |
| $0.310 | -0.180 | -36.7% | $0.350 | $0.360 | $0.280 | 40,069,500 | |
| $0.490 | +0.020 | +4.3% | $0.470 | $0.510 | $0.460 | 328,400 | |
| $0.470 | -0.110 | -19.0% | $0.550 | $0.580 | $0.420 | 658,900 | |
| $0.580 | 0.000 | 0.0% | $0.580 | $0.620 | $0.570 | 99,600 | |
| $0.580 | 0.000 | 0.0% | $0.580 | $0.670 | $0.560 | 93,100 | |
| $0.580 | -0.030 | -4.9% | $0.630 | $0.630 | $0.580 | 65,600 | |
| $0.610 | -0.020 | -3.2% | $0.600 | $0.630 | $0.580 | 148,300 | |
| $0.630 | -0.060 | -8.7% | $0.670 | $0.710 | $0.620 | 133,900 | |
| $0.690 | -0.040 | -5.5% | $0.730 | $0.730 | $0.670 | 152,700 | |
| $0.730 | -0.050 | -6.4% | $0.770 | $0.770 | $0.730 | 160,700 | |
| $0.780 | -0.010 | -1.3% | $0.790 | $0.820 | $0.780 | 118,100 | |
| $0.790 | -0.060 | -7.1% | $0.820 | $0.830 | $0.780 | 216,800 | |
| $0.850 | -0.020 | -2.3% | $0.780 | $0.900 | $0.760 | 8,498,700 | |
| $0.870 | +0.020 | +2.4% | $0.860 | $0.870 | $0.830 | 149,700 | |
| $0.850 | -0.080 | -8.6% | $0.880 | $0.890 | $0.820 | 272,200 | |
| $0.930 | 0.000 | 0.0% | $0.930 | $0.950 | $0.910 | 120,500 | |
| $0.930 | -0.030 | -3.1% | $0.940 | $0.960 | $0.910 | 170,300 | |
| $0.960 | -0.030 | -3.0% | $0.970 | $0.980 | $0.920 | 401,800 | |
| $0.990 | -0.160 | -13.9% | $1.090 | $1.090 | $0.920 | 1,288,600 | |
| $1.150 | -0.520 | -31.1% | $2.060 | $2.130 | $1.100 | 35,362,700 | |
| $1.670 | -0.160 | -8.7% | $1.850 | $1.850 | $1.630 | 176,000 | |
| $1.830 | +0.050 | +2.8% | $1.760 | $1.850 | $1.690 | 101,500 | |
| $1.780 | -0.210 | -10.6% | $1.970 | $2.000 | $1.780 | 109,800 | |
| $1.990 | -0.060 | -2.9% | $2.080 | $2.100 | $1.900 | 128,400 | |
| $2.050 | +0.060 | +3.0% | $1.990 | $2.080 | $1.920 | 361,800 | |
| $1.990 | +0.130 | +7.0% | $1.920 | $2.150 | $1.890 | 281,200 | |
| $1.860 | -0.230 | -11.0% | $2.040 | $2.050 | $1.840 | 125,200 | |
| $2.090 | -0.080 | -3.7% | $2.180 | $2.180 | $2.080 | 54,500 | |
| $2.170 | +0.050 | +2.4% | $2.170 | $2.170 | $2.070 | 97,300 | |
| $2.120 | -0.100 | -4.5% | $2.250 | $2.280 | $2.060 | 56,400 | |
| $2.220 | +0.170 | +8.3% | $2.110 | $2.230 | $2.030 | 141,000 | |
| $2.050 | -0.270 | -11.6% | $2.240 | $2.300 | $2.030 | 286,600 | |
| $2.320 | +0.140 | +6.4% | $2.200 | $2.610 | $2.130 | 5,084,500 | |
| $2.180 | +0.300 | +16.0% | $1.890 | $2.270 | $1.890 | 500,000 | |
| $1.880 | -0.020 | -1.1% | $1.880 | $1.980 | $1.870 | 90,200 | |
| $1.900 | -0.170 | -8.2% | $2.100 | $2.160 | $1.860 | 251,200 | |
| $2.070 | -0.690 | -25.0% | $2.470 | $2.640 | $2.060 | 509,100 | |
| $2.760 | +0.260 | +10.4% | $2.680 | $2.860 | $2.530 | 3,568,500 | |
| $2.500 | +0.200 | +8.7% | $2.230 | $2.580 | $2.220 | 13,655,500 | |
| $2.300 | -0.190 | -7.6% | $2.440 | $2.440 | $2.220 | 95,800 | |
| $2.490 | +0.040 | +1.6% | $2.620 | $2.620 | $2.350 | 213,500 | |
| $2.450 | +0.160 | +7.0% | $2.230 | $2.570 | $2.200 | 377,200 | |
| $2.290 | +0.160 | +7.5% | $2.100 | $2.350 | $2.100 | 213,343 | |
| $2.130 | -0.110 | -4.9% | $2.200 | $2.290 | $2.100 | 39,957 | |
| $2.240 | +0.050 | +2.3% | $2.180 | $2.340 | $2.170 | 70,500 | |
| $2.190 | -0.050 | -2.2% | $2.170 | $2.240 | $2.130 | 85,100 | |
| $2.240 | -0.060 | -2.6% | $2.230 | $2.350 | $2.160 | 80,200 | |
| $2.300 | +0.140 | +6.5% | $2.140 | $2.300 | $2.040 | 102,300 | |
| $2.160 | -0.110 | -4.8% | $2.150 | $2.250 | $2.130 | 32,700 | |
| $2.270 | -0.060 | -2.6% | $2.330 | $2.330 | $2.070 | 106,300 | |
| $2.330 | -0.030 | -1.3% | $2.340 | $2.350 | $2.170 | 287,100 | |
| $2.360 | 0.000 | 0.0% | $2.300 | $2.460 | $2.220 | 70,500 | |
| $2.360 | +0.010 | +0.4% | $2.260 | $2.380 | $2.240 | 46,600 | |
| $2.350 | +0.130 | +5.9% | $2.190 | $2.450 | $2.180 | 194,400 | |
| $2.220 | -0.010 | -0.4% | $2.190 | $2.270 | $2.140 | 46,200 | |
| $2.230 | -0.080 | -3.5% | $2.260 | $2.360 | $2.130 | 102,600 | |
| $2.310 | +0.090 | +4.1% | $2.210 | $2.500 | $2.210 | 163,900 | |
| $2.220 | +0.060 | +2.8% | $2.120 | $2.320 | $2.020 | 165,400 |
- Ticker
- NASDAQ:LABT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 21, 2026
Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
Latest deck · Oct 21, 2026
Investor Presentation (October 2026)
Investor deck · 22 slides
Latest news
Lakewood-Amedex Biotherapeutics Presents Data Highlighting Nu-3's Broad-Spectrum Antimicrobial Activity and Low Potential for Resistance at IDWeek 2026
Oct 21, 2026
Closed $0.47 (-19.0%) on Oct 21, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Preclinical Data in Urinary Tract and Pulmonary Infection Indications with Bisphosphocin® Compounds
Oct 7, 2026
Closed $0.85 (-2.3%) on Oct 7, 2026
Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
Oct 1, 2026
Closed $0.93 (-3.1%) on Oct 1, 2026
Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
Sep 28, 2026
Closed $1.15 (-31.1%) on Sep 28, 2026
Lakewood-Amedex Biotherapeutics CEO Issues Letter to Shareholders Highlighting Transformational Progress and Outlook for Nu-3
Sep 21, 2026
Closed $2.05 (+3.0%) on Sep 21, 2026
Lakewood-Amedex Biotherapeutics Announces IRB Approval and Clinical Site Readiness to Initiate Phase 2a Clinical Trial of Nu-3 for the Treatment of Infected Diabetic Foot Ulcers
Sep 18, 2026
Closed $1.99 (+7.0%) on Sep 18, 2026
Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference
Sep 8, 2026
Closed $2.18 (+16.0%) on Sep 8, 2026
Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data in Response to National Action Plan of Presidential Advisory Council on Combating Antibiotic Resistant Bacteria
Jul 22, 2026
Closed $3.41 (+83.3%) on Jul 22, 2026
Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel
Jul 15, 2026
Closed $2.43 (-4.7%) on Jul 15, 2026
Lakewood-Amedex Biotherapeutics Supports Reintroduction of the PASTEUR Act and Focus on Combating Antimicrobial Resistance
Jul 7, 2026
Closed $2.39 (-12.8%) on Jul 7, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 22 slides · Oct 21, 2026
Investor Presentation (September 2026)
Investor deck · 21 slides · Sep 25, 2026
Investor Presentation (July 2026)
Investor deck · 21 slides · Jul 15, 2026
Lakewood-Amedex Biotherapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 19 in all · newest Oct 21, 2026 · oldest 2026
- Decks
- 3 decks · latest Oct 21, 2026
Where Lakewood-Amedex Biotherapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LABT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LABT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Lakewood-Amedex Biotherapeutics Inc.